GONADOTROPIN-RELEASING HORMONE ACTION

促性腺激素释放激素作用

基本信息

  • 批准号:
    8173169
  • 负责人:
  • 金额:
    $ 4.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. These are highly translational studies in which we have observed that the underlying basis of mutational disease is frequently the mis-routing of otherwise functional proteins, in this case a receptorbut other labs have now confirmed this for other receptors, ion channels and enzymes. We have shown that these mutant receptors can be rescued and restored to function by pharmacological chaperones. We have determined that the regulation of routing is also a normal type of post-translational regulation that occurs in routine cell function and can be controlled. During the prior period we have shown that misfolded hGnRHR can be refolded so that therapeutic agents need not be continuously present. We have also shown that control of hGnRHR helps explain the basics of the ability of this receptor to respond to both amplitude and frequency modulated signals. GnRHR analogs were screened for potential therapeutic action and a review was published.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

P. MICHAEL CONN其他文献

P. MICHAEL CONN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('P. MICHAEL CONN', 18)}}的其他基金

Mouse Model for Diseases of Protein Misfolding
蛋白质错误折叠疾病的小鼠模型
  • 批准号:
    8805919
  • 财政年份:
    2014
  • 资助金额:
    $ 4.76万
  • 项目类别:
High Throughput Screening for Pharmacoperones of the V2 Receptor
V2 受体药用酮的高通量筛选
  • 批准号:
    8696856
  • 财政年份:
    2013
  • 资助金额:
    $ 4.76万
  • 项目类别:
High Throughput Screening for Pharmacoperones of the V2 Receptor
V2 受体药用酮的高通量筛选
  • 批准号:
    8555110
  • 财政年份:
    2013
  • 资助金额:
    $ 4.76万
  • 项目类别:
High Throughput Screening for Pharmacoperones of the V2 Receptor
V2 受体药用酮的高通量筛选
  • 批准号:
    8816998
  • 财政年份:
    2013
  • 资助金额:
    $ 4.76万
  • 项目类别:
Mouse Model for Diseases of Protein Misfolding
蛋白质错误折叠疾病的小鼠模型
  • 批准号:
    8208973
  • 财政年份:
    2011
  • 资助金额:
    $ 4.76万
  • 项目类别:
MOUSE MODEL FOR DISEASES OF PROTEIN MISFOLDING
蛋白质错误折叠疾病的小鼠模型
  • 批准号:
    8357844
  • 财政年份:
    2011
  • 资助金额:
    $ 4.76万
  • 项目类别:
HIGH THROUGHPUT SCREENING ASSAY DEVELOPMENT FOR PHARMACOPERONES
制药公司的高通量筛选检测方法开发
  • 批准号:
    8357845
  • 财政年份:
    2011
  • 资助金额:
    $ 4.76万
  • 项目类别:
Mouse Model for Diseases of Protein Misfolding
蛋白质错误折叠疾病的小鼠模型
  • 批准号:
    8033595
  • 财政年份:
    2011
  • 资助金额:
    $ 4.76万
  • 项目类别:
GONADOTROPIN-RELEASING HORMONE ACTION
促性腺激素释放激素作用
  • 批准号:
    8357723
  • 财政年份:
    2011
  • 资助金额:
    $ 4.76万
  • 项目类别:
High Throughput Screening Assay Development for Pharmacoperones
药用酮的高通量筛选试验开发
  • 批准号:
    8259448
  • 财政年份:
    2010
  • 资助金额:
    $ 4.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了